Outlook Therapeutics Inc. (OTLK)
Market Closed
1 Sep, 20:00
$
0. 62
-0.01
-1.564%
$
120.59M Market Cap
- P/E Ratio
- Div Yield
3.55M Volume
-0.23 Eps
$ 0.63
Previous Close 
Want to track OTLK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Outlook Therapeutics Inc. (OTLK) Statistics
Valuation metrics
Market Cap 120.59M
Enterprise value 127.78M
Trailing P/E (ttm) -0.34
Forward P/E -1.34
PEG ratio 0
Price/Sales (ttm) -103.68
Price/Book (mrq) -1.58
Enterprise Value/Revenue -109.86
Enterprise Value/EBITDA -2.05
Overview
Shares outstanding 64.56M
Float 67.73M
Shares short 3.69M
% Held by insiders 0.18%
% Held by institutions 0.08%
Average volume (10 days) 9.48M
Average volume (90 days) 13.03M
Price summary
52-Week low 0.16
52-Week high 2.54
Beta -0.08
50-Day moving average 1.12
200-Day moving average 0.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 14 Mar 2024
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 52.55%
Operating margin 47.83%
Operational effectiveness
Return on assets -2.33%
Return on equity 2.22%
Income Statement
Revenue (ttm) 205.7K
Revenue per share (ttm) -0.05
Quarterly revenue growth (yoy) 12.16%
Gross profit (ttm) -22.34M
EBITDA -58.82M
Net income to common (ttm) -102.86M
Diluted EPS (ttm) -2.4
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 8.68M
Total cash per share (mrq) 0.44
Total debt (mrq) 36.89M
Total Debt/Equity (mrq) -1.77
Current ratio (mrq) 0.81%
Book value per share (mrq) -0.41
Cash Flow
Cash flow statement -55.8M
Levered free cash flow (LFCF) -34.42M
